2 patient evaluations for Carbidopa-Entacapone-Levodopa taken for the purpose of 'Parkinson's disease' with a perceived effectiveness rating of None

6 members have decided to share their profiles only with other members of PatientsLikeMe.

Jun 13, 2017 (Started May 19, 2017)

  • Effectiveness
    None (for Parkinson's disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50-200-200 mg Five times daily
Advice & Tips: I have advanced pd. We were hoping it might help me a little bit more than Rytary. It didn't.
Cost: $200+ monthly

  • 0 helpful marks

Sep 19, 2009 (Started Sep 13, 2009)

  • Effectiveness
    None (for Parkinson's disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 5 x 25 mg-200 mg-100 mg Daily
Advice & Tips: none for all 3
Cost: $200+ monthly

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Carbidopa-Entacapone-Levodopa